Enzyme replacement therapy for mucopolysaccharidosis VI: long-term cardiac effects of galsulfase (Naglazyme®) therapy (Q36662791)

15 August 2017

Enzyme replacement therapy for mucopolysaccharidosis VI: long-term cardiac effects of galsulfase (Naglazyme®) therapy (English)

1 reference

enzyme replacement therapy

15 August 2017

0 references

mucopolysaccharidosis VI

1 reference

6

R Giugliani

1 reference

15 August 2017

19

J J Hopwood

1 reference

15 August 2017

E Braunlin

1

1 reference

15 August 2017

H Rosenfeld

2

1 reference

15 August 2017

C Kampmann

3

1 reference

15 August 2017

J Johnson

4

1 reference

15 August 2017

M Beck

5

1 reference

15 August 2017

N Guffon

7

1 reference

15 August 2017

D Ketteridge

8

1 reference

15 August 2017

C M Sá Miranda

9

1 reference

15 August 2017

M Scarpa

10

1 reference

15 August 2017

I V Schwartz

11

1 reference

15 August 2017

E Leão Teles

12

1 reference

15 August 2017

J E Wraith

13

1 reference

15 August 2017

P Barrios

14

1 reference

15 August 2017

E Dias da Silva

15

1 reference

15 August 2017

G Kurio

16

1 reference

15 August 2017

M Richardson

17

1 reference

15 August 2017

G Gildengorin

18

1 reference

15 August 2017

M Imperiale

20

1 reference

15 August 2017

A Schatz

21

1 reference

15 August 2017

C Decker

22

1 reference

15 August 2017

P Harmatz

23

1 reference

15 August 2017

MPS VI Study Group

24

1 reference

15 August 2017

5 June 2012

1 reference

Journal of Inherited Metabolic Disease

15 August 2017

1 reference

15 August 2017

36

1 reference

15 August 2017

385-394

1 reference

15 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s10545-012-9481-2

15 August 2017

0 references

cites work

Enzyme replacement therapy for mucopolysaccharidosis VI: Growth and pubertal development in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590402

Enzyme replacement therapy for mucopolysaccharidosis VI: evaluation of long-term pulmonary function in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590402

Mucopolysaccharidosis VI: the Italian experience

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590402

The Vascularity of the Valves of the Human Heart

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590402

Reliability of multicenter pediatric echocardiographic measurements of left ventricular structure and function: the prospective P(2)C(2) HIV study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590402

Doppler aortic flow velocity measurement in healthy children

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590402

Normal values of M mode echocardiographic measurements of more than 2000 healthy infants and children in central Europe

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590402

Mitral and aortic regurgitation in 84 patients with mucopolysaccharidoses

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590402

Mitral stenosis in the Maroteaux-Lamy syndrome: a treatable cause of dyspnoea

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590402

Regression equations for calculation of z scores of cardiac structures in a large cohort of healthy infants, children, and adolescents: an echocardiographic study.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590402

Bone marrow transplantation for Maroteaux-Lamy syndrome (MPS VI): long-term follow-up.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590402

Validity of echocardiographic measurement in an epidemiological study. Project HeartBeat!

28 June 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-012-9481-2

Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-012-9481-2

Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-ac

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-012-9481-2

Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-012-9481-2

Echocardiographic study of paediatric patients with mucopolysaccharidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-012-9481-2

Clinical and biochemical study of 28 patients with mucopolysaccharidosis type VI

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-012-9481-2

Echocardiographic Assessment of Valve Stenosis: EAE/ASE Recommendations for Clinical Practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-012-9481-2

Cardiovascular changes in children with mucopolysaccharide storage diseases and related disorders--clinical and echocardiographic findings in 64 patients

21 January 2018

1 reference

12 December 2020

The natural course and the impact of therapies of cardiac involvement in the mucopolysaccharidoses

1 reference

12 December 2020

Enzyme replacement therapy for mucopolysaccharidosis VI from 8 weeks of age--a sibling control study

1 reference

12 December 2020

Valvular heart disease in four patients with Maroteaux-Lamy syndrome

1 reference

12 December 2020

Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, o

1 reference

12 December 2020

Threshold effect of urinary glycosaminoglycans and the walk test as indicators of disease progression in a survey of subjects with Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)

1 reference

12 December 2020

Combined aortic and mitral valve replacement in an adult with mucopolysaccharidosis (Maroteaux-Lamy syndrome)

1 reference

12 December 2020

Recommendations for quantification methods during the performance of a pediatric echocardiogram: a report from the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council

1 reference

12 December 2020

10.1007/S10545-012-9481-2

Identifiers

DOI

1 reference

15 August 2017

1 reference

15 August 2017

1 reference